Borderline Personality Disorder: all 278 studies

Page 3 of 3. Open to participants first (70), then studies with results posted, then the rest; newest registration first within each.

• Use of Care Services by Patients With Borderline Personality DisorderCompletedNCT02829658
• Emotional and Non-emotional Regulation in Patients With Emotional Instability and ADHDStatus unknownNCT02797873Not applicable
• fMRI in ImpulsivityCompletedNCT02755181
• Nalmefene in Alcohol Dependence and Borderline Personality DisorderStatus unknownNCT02752503Not applicable
• Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)CompletedNCT02728778Phase 2
• CPT Group for DBT Clients With Co-Occurring Borderline Personality Disorder and PTSDCompletedNCT02574429Not applicable
• Neural Correlates of Stress HormonesCompletedNCT02523664Not applicable
• College Students Who Self-HarmWithdrawnNCT02522143Not applicable
• Evaluation of AIT StudyCompletedNCT02518906Not applicable
• Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress DisorderCompletedNCT02517723Not applicable
• Changes in the Brain as Borderline Patients Learn to Regulate Their EmotionsCompletedNCT02465697Not applicable
• Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality DisorderCompletedNCT02397031Not applicable
• DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical & Cost Effectiveness of a 6 mo. TreatmentCompletedNCT02387736Not applicable
• Biomarkers of Change in BPD After Metacognitive Interpersonal Therapy-standard ApproachCompletedNCT02370316Not applicable
• Peer Support for Severe Mental DisordersCompletedNCT02276469Not applicable
• TMS in Borderline Personality Disorder PatientsCompletedNCT02273674Not applicable
• Staff Nurse Perceptions of MBT Skills Training for Working With BPD in AMHCompletedNCT02239055
• The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy AdultsSuspendedNCT02225600Not applicable
• Supportive Program for Mother With BPDCompletedNCT02203708Not applicable
• Examining Dose-Related Effects of Oxytocin on Social Cognition Across PopulationsTerminatedNCT02149823Phase 1
• Methylation Status of BDNF Gene After Dialectical Behavior Therapy in BPDCompletedNCT02134223Not applicable
• Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder TreatmentCompletedNCT02125942Not applicable
• Acetaminophen and Social ProcessesCompletedNCT02108990Phase 2
• MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled TrialCompletedNCT02068326Not applicable
• Cognitive Rehabilitation Versus Psychoeducation in Psychosocial Functioning of Borderline Personality DisorderCompletedNCT02033044Not applicable
• ERGT for Women Engaging in NSSI - an Effectiveness StudyCompletedNCT01986257Not applicable
• Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality DisorderCompletedNCT01952405Not applicable
• Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality DisorderCompletedNCT01912391Phase 3
• Intensified, Inpatient Adaptation of Dialectical Behavior Therapy (DBT)Status unknownNCT01904227Not applicable
• Effects of Motive-Oriented Therapeutic Relationship in the Early-Phase Treatment of Borderline Personality DisorderCompletedNCT01896024Not applicable
• Neuropsychiatric Mechanisms of Change in Mentalization Based Treatment of Borderline Personality Disorder (MENTAB)TerminatedNCT01720953
• Psychoeducation of Borderline PatientsCompletedNCT01719731Not applicable
• Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality DisorderStatus unknownNCT01683136Not applicable
• Evaluating a Novel Method of Generalizing Emotion RegulationCompletedNCT01653548Not applicable
• Evaluation of a Modified Dialectical Behavior Therapy ProgramCompletedNCT01635556
• Trial of Effect of High-frequency Transcranial Magnetic Stimulation in the Management of Borderline Personality DisorderStatus unknownNCT01602497Not applicable
• Promoting Recovery Processes in Women With Borderline Personality Disorder Using a Dynamic Cognitive InterventionStatus unknownNCT01531634Not applicable
• Efficacy of Dialectical Behavior Therapy Versus CAMS-informed Supportive Psychotherapy on Self Harming BehaviorCompletedNCT01512602Not applicable
• Event Related Potentials in Borderline Personality Disorder and Major DepressionTerminatedNCT01469663
• A Double Blind Crossover Study on the Effect of MPH on Decision-making Ability of Adults With BPD Compared to Adults With ADHD and Healthy AdultsStatus unknownNCT01426984Not applicable
• Creativity Group for Borderline Personality DisorderCompletedNCT01343550Phase 1
• Circadian Sleep-wake Cycles and Light Therapy in Borderline Personality DisorderCompletedNCT01311193Not applicable
• "The Effects of Oxytocin on Patients With Borderline Personality Disorder"CompletedNCT01243658Not applicable
• 20 Weeks DBT Group Skills Training StudyCompletedNCT01193205Phase 1
• Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality DisorderCompletedNCT01133301Phase 2
• Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in AdolescentsCompletedNCT01111734Phase 1
• Calling for Care: Cell Phones for Mood Telemetry in TeensCompletedNCT01083823Not applicable
• Treating PTSD in Patients With Borderline Personality DisorderCompletedNCT01081314Phase 1/2
• Transcranial Magnetic Stimulation for Borderline Personality DisorderCompletedNCT01076933Not applicable
• A Randomized Control Trial of Narrative Exposure Therapy Versus Treatment as Usual in the Therapy of Borderline Personality DisorderStatus unknownNCT01033708Not applicable
• Ziprasidone in the Treatment of Borderline Personality DisorderCompletedNCT00635921Phase 2
• Study of Lamotrigine Treatment of Affective Instability in Borderline Personality DisorderCompletedNCT00634062Phase 4
• Effectiveness of a 24 Hour Phone Line on the Rate of Suicide Attempts in Borderline PatientsCompletedNCT00603421Not applicable
• BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality DisorderCompletedNCT00538135Phase 3
• Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol DependenceWithdrawnNCT00463775Phase 3
• Efficacy of Omega-3 Fatty Acids on Borderline Personality DisorderStatus unknownNCT00437099Phase 4
• Guanfacine to Treat Borderline Personality DisorderStatus unknownNCT00358969Not applicable
• MRI Imaging in Borderline Personality DisorderCompletedNCT00275288
• Outcome of Crisis Intervention for Subjects With Borderline Personality Disorder or Post-Traumatic Stress DisorderStatus unknownNCT00269139Phase 1
• DBT and Escitalopram in Borderline Personality DisorderStatus unknownNCT00255554Not applicable
• Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered PatientsCompletedNCT00254748Phase 2
• DBT in Borderline Personality DisorderStatus unknownNCT00252031Not applicable
• Effectiveness of Group Based Schema Therapy in the Treatment of Personality DisordersCompletedNCT00247234Not applicable
• Depakote ER in Borderline Personality DisorderCompletedNCT00222482Not applicable
• Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality DisorderCompletedNCT00204347Phase 4
• Chrysalis Day Program Body Mass Index StudyCompletedNCT00202215Not applicable
• User Satisfaction Survey - Personality Disorder ServiceCompletedNCT00202202Not applicable
• Treatment of Suicidal Women With Borderline Personality DisorderCompletedNCT00183651Phase 2
• Effects of Comorbid Personality Disorder on the Treatment of Bipolar I DisorderCompletedNCT00178061Phase 4
• Hope for the Chronically Suicidal PatientCompletedNCT00154154Not applicable
• Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use DisorderCompletedNCT00145678Phase 2
• Cognitive Therapy Versus Supportive Therapy in Borderline Personality DisorderStatus unknownNCT00131781Not applicable
• Naltrexone in Borderline Personality DisorderTerminatedNCT00124839Phase 3
• Quetiapine Treatment for Symptoms Associated With Borderline Personality DisorderCompletedNCT00122070Phase 3
• Evaluation of DBT Compared to Drug Counseling for Opiate AddictsCompletedNCT00117741Not applicable
• Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00091650Phase 3
• Efficacy and Safety of Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00088036Phase 3
• Treatment for Borderline Personality DisorderCompletedNCT00055315Not applicable

← Borderline Personality Disorder overview